MORF - Morphic Holding, Inc.
IEX Last Trade
56.985
56.985 100.000%
Share volume: 0
Last Updated: Fri 16 Aug 2024 11:42:10 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
24%
Profitability
25%
Dept financing
2%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2019 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.58%
Return on assets
-5.44%
Return on sales
-1224.3%
Return on invested capital
129.17%
Total debt ratio
19%
Debt ratio change over timeo
-0.72%
Current Ratio
17.67%
Quick Ratio
19.43%
Cash Position Ratio
16.97%
Short-term ratios 31-Dec-2022 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-6.17%
Return on assets
-6.95%
Return on sales
-7524.95%
Return on invested capital
326.1%
Total debt ratio
3.09%
Debt ratio change over timeo
-1.03%
Current Ratio
35.3%
Quick Ratio
35.3%
Cash Position Ratio
34.58%
Last quarter ratios 31-Dec-2023
The data are presented for the financials results of the last quarter.
Return on equity
-5.84%
Return on assets
-6.84%
Return on sales
0%
Return on invested capital
212.27%
Total debt ratio
3.53%
Debt ratio change over time
-0.98%
Current Ratio
28.94%
Quick Ratio
28.94%
Cash Position Ratio
28.43%
Performance ratios (change over 4 years) 31-Dec-2019 - 31-Dec-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.03%
Return on assets
-102.6%
Return on sales
-651.48%
Return on invested capital
-162.76%
Total debt ratio
-72.28%
Debt ratio change over time
-0.72%
Current Ratio
-6.5%
Quick Ratio
-9.1%
Cash Position Ratio
-7.2%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MORF | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -6.58% | 10.2% | 35.82% | 7.59% |
| Return on assets | -5.44% | 2.89% | 3.31% | 5.76% |
| Return on sales | -1224.3% | 29.84% | 34.06% | 41.2% |
| Return on invested capital | 129.17% | 3.06% | 5.78% | 20.17% |
| Profitability | 25% | 38% | 61% | 59% |
| Total debt ratio | 19% | 91.31% | 89.91% | 26.84% |
| Debt ratio change over time | -0.72% | 295.05% | -10.03% | 1.11% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 35.3% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 35.3% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 34.58% | 0.31% | 1.72% | 2.92% |
| Liquididy | 75% | 3% | 6% | 14% |
| Short-term ratios | MORF | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -6.17% | 9.95% | 27.09% | 4.01% |
| Return on assets | -6.95% | 2.47% | 2.17% | 3.36% |
| Return on sales | -7524.95% | 24.58% | 28.87% | 32.26% |
| Return on invested capital | 326.1% | 1.71% | 5.84% | 9.7% |
| Profitability | 25% | 47% | 64% | 54% |
| Total debt ratio | 3.09% | 91.02% | 92.9% | 21.89% |
| Debt ratio change over time | -1.03% | 107.3% | -84.55% | 1.71% |
| Dept financing | 1% | 49% | 25% | 6% |
| Current Ratio | 35.3% | 0.92% | 2.61% | 5.44% |
| Quick Ratio | 35.3% | 0.8% | 2.24% | 4.68% |
| Cash Position Ratio | 34.58% | 0.31% | 1.72% | 2.92% |
| Liquididy | 75% | 1% | 5% | 9% |